Polymers in Medicine

Polim. Med.
Scopus CiteScore: 3.5 (CiteScore Tracker 3.6)
Index Copernicus (ICV 2023) – 121.14
MEiN – 70
ISSN 0370-0747 (print)
ISSN 2451-2699 (online) 
Periodicity – biannual

Download original text (EN)

Polymers in Medicine

2020, vol. 50, nr 2, July-December, p. 79–82

doi: 10.17219/pim/131643

Publication type: review article

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Polymers with antiviral properties: A brief review

Sławomir Zmonarski1,C,D,E,F, Jakub Stojanowski2,A,B,C,D, Joanna Zmonarska2,D

1 Department of Nephrology and Transplantation Medicine, Wroclaw Medical University & University Hospital, Poland

2 Students’ Scientific Club, Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Poland

Abstract

Viruses that are pathogenic to humans and livestock pose a serious epidemiological threat and challenge the world’s population. The SARS-CoV-2/COVID-19 pandemic has made the world aware of the scale of the threat. The surfaces of various materials can be a source of viruses that remain temporarily contagious in the environment. Few polymers have antiviral effects that reduce infectivity or the presence of a virus in the human environment. Some of the effects are due to certain physical properties, e.g., high hydrophobicity. Other materials owe their antiviral activity to a modified physicochemical structure favoring the action on specific virus receptors or on their biochemistry. Current research areas include: gluten, polyvinylidene fluoride, polyimide, polylactic acid, graphene oxide, and polyurethane bound to copper oxide. The future belongs to multi-component mixtures or very thin multilayer systems. The rational direction of research work is the search for materials with a balanced specificity in relation to the most dangerous viruses and universality in relation to other viruses.

Key words

COVID-19, invasive virions, virucidal properties, antiviral polymers, heavy metal particles

References (17)

  1. Sun Z, Ostrikov K. Future antiviral surfaces: Lessons from COVID-19 pandemic. Sustainable Materials and Technologies 2020;25:e00203–e00203.
  2. Zhu N, Zhang D, Wang W, et al; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
  3. Biryukov J, Boydston JA, Dunning RA, et al. Increasing temperature and relative humidity accelerates inactivation of SARS-CoV-2 on surfaces. mSphere 2020;5(4):e00441–e00420.
  4. Khan MM, Parab SR, Paranjape M. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic. Am J Otolaryngol. 2020;41(5):102618–102618.
  5. Schandock F, Riber CF, Röcker A, et al. Macromolecular antiviral agents against Zika, Ebola, SARS, and other pathogenic ciruses. Adv Healthc Mater. 2017;6(23):1700748.
  6. Dres M, Burrel S, Boutolleau D, et al. SARS-CoV-2 does not spread through extracorporeal membrane oxygenation or dialysis membranes. Am J Respir Crit Care Med. 2020;202(3):458–460.
  7. Das O, Neisiany RE, Capezza AJ, et al. The need for fully bio-based facemasks to counter coronavirus outbreaks: A perspective. The Science of the Total Environment. 2020;736:139611–139611.
  8. Leung WWF, Sun Q. Electrostatic charged nanofiber filter for filtering airborne novel coronavirus (COVID-19) and nano-aerosols. Sep Purif Technol. 2020;250:116886–116886.
  9. El-Atab N, Qaiser N, Badghaish H, Shaikh SF, Hussain MM. Flexible nanoporous template for the design and development of reusable anti-COVID-19 hydrophobic face masks. ACS Nano. 2020;14(6):7659–7665.
  10. He H, Gao M, Illés B, Molnar K. 3D printed and electrospun, transparent, hierarchical polylactic acid mask nanoporous filter. Int J Bioprint. 2020;6(4):278.
  11. Ye S, Shao K, Li Z, et al. Antiviral activity of graphene oxide: How sharp edged structure and charge matter. ACS Appl Mater Interfaces. 2015;7(38):21571–21579.
  12. Balagna C, Perero S, Percivalle E, Nepita EV, Ferraris M. Virucidal effect against coronavirus SARS-CoV-2 of a silver nanocluster/silica composite sputtered coating. Open Ceramics. 2020;1:100006–100006.
  13. van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–1567.
  14. Kondor S, Grant CG, Liacouras P, et al. On demand additive manufacturing of a basic surgical kit. J Med Devices. 2013;7: 30916.
  15. Zuniga JM, Cortes A. The role of additive manufacturing and antimicrobial polymers in the COVID-19 pandemic. Expert Rev Med Devices. 2020;17(6):477–481.
  16. Behzadinasab S, Chin A, Hosseini M, Poon L, Ducker WA. A surface coating that rapidly inactivates SARS-CoV-2. ACS Appl Mater Interfaces. 2020;12:34723–34727.
  17. Ahmed MK, Afifi M, Uskoković V. Protecting healthcare workers during COVID-19 pandemic with nanotechnology: A protocol for a new device from Egypt. J Infect Public Health. 2020;13(9):1243–1246.
© Wroclaw Medical University